Skip to main content

Race and Ethnicity

The FDA's Sentinel System seeks to improve data capture of race and ethnicity for pharmacoepidemiologic studies. Utilizing these variables can help to characterize medication use and identify groups at high or low risk of health outcomes of interest. Descriptions of efforts led by the Center for Drug Evaluation and Research are shown below. Please visit the links to learn more about each area of activity.